Frank Cappelleri breaks down the trade on the iShares U.S. Pharmaceuticals ETF.
What Rivian’s venture with Volkswagen means for the EV maker, broader auto industry
Rivian’s latest partnership with Volkswagen could prove a major boon for investors and the broader auto industry, according to some Wall Street analysts.
Investor Neil Hennessy says megacap tech trade is ‘over’ and to buy these two stocks instead
The money manager said investors should now look at value stocks instead.
Apple shares will rally to $260 as company beats Android in AI race, Rosenblatt says
Rosenblatt sees Apple edging out its competitors in the AI race due to its strong privacy features.
How to get long an energy stock with substantial comeback potential, according to options trader
Tony Zhang breaks down a trade in driller SLB.
JPMorgan upgrades Campbell Soup, saying its recently-acquired Rao’s sauce business is thriving
The bank now has an overweight recommendation on the stock for the first time since 2009.
Your 401(k) is up, and a new report shows increased savings. But Americans need to do more
Returns are up and people are saving more. But account balances for the median 401(k) are too low and Americans are still very reliant on Social Security.
Wednesday’s analyst calls: Stifel gets bullish on Tesla, FedEx seen rallying 40%
Post Content
Here are Oppenheimer’s top stock picks heading into July
Oppenheimer’s top stock ideas heading into the new trading month include a large retailer and a chipmaker.
Wednesday could be a big day for AI chip stocks as their market-leading rally stalls
Two key events Wednesday could provide a much-needed catalyst for the recently troubled semiconductor sector.